Werner Kleophas

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis

Hugh C. Rayner, Maria Larkina, Mia Wang et al. · Clinical Journal of the American Society of Nephrology · 2017 · 259 citations · Full text

The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL‐cholesterol plasma concentrations and the course of coronary heart disease*

P. Schuff‐Werner, H Gohlke, U. Bartmann et al. · European Journal of Clinical Investigation · 1994 · 149 citations

Uric Acid Levels and All-Cause and Cardiovascular Mortality in the Hemodialysis Population

Walead Latif, Angelo Karaboyas, Tong Lin et al. · Clinical Journal of the American Society of Nephrology · 2011 · 145 citations · Full text